Phase II (Treatment) Study of Oxaliplatin and Capecitabine in Advanced Head and Neck Malignancies
University of Louisville
University of Louisville
University of California, Irvine
University of Kansas Medical Center
Dana-Farber Cancer Institute
University of California, Irvine
University of Miami
Nang Kuang Pharmaceutical Co., Ltd.
Minneapolis Veterans Affairs Medical Center
National Cancer Institute (NCI)
Vanderbilt-Ingram Cancer Center
Sanofi